Summary
compilation of questions and responses from an industry day event related to the BD21 project. The questions cover various topics such as industry investment certainty, relationships between DHS and states, potential conflicts of interest, timeline for plan approvals, differences between BD21 and previous efforts, resource concerns for state and locals, use of anomaly algorithms and machine learning in BD21, accreditation process, budget authority for BioWatch and BD21, procurement details, testing history of BD21, use of pre-work by industry, definitions of COTS and GOTS, field screening devices specifications, MIT Lab collaborations, operational budgets disclosure timeline, upcoming acquisition efforts focus on system integration for indoor applications, deployment applications indoors and outdoors, requirements for CTE and system integration, detection capabilities of triggers within BD21, and future technology upgrades handling.
The document also mentions the publication of slides on beta.sam.gov and the intention not to release certain information at this time.